Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeffrey A. Zonder, MD
Barbara Ann Karmanos Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Rocky Mountain Cancer Centers/rocky Mountain Blood & Marrow Transplant Program
Denver, Colorado, United States
- Boston University Cancer Research Center
Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan, United States
- Providence Cancer Institute at Providence Hospital - Southfield Campus
Southfield, Michigan, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Upmc Cancer Centers
Pittsburgh, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2007
- Primary completion
- 31 Oct 2010
- Completion
- 6 Jun 2019
- Last update posted
- 22 Dec 2023
- Registered enrollment
- 35
- Registry id
- NCT00520767
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.